ERASE-LC is funded by a research grant from for people with long COVID, sponsored by the and managed by the ¶¶Òõ¶ÌÊÓƵ’s
Peninsula Clinical Trials Unit (PenCTU)
. (Professor in Clinical Exercise Science) is the Chief Investigator and will be leading the research.
One in ten people experience symptoms in the weeks, months and even years following a COVID-19 infection. These symptoms affect people in different ways and there is evidence that they impact physical and mental well-being and cognitive function. These collections of symptoms are called long COVID. Currently, there are no treatments available to address these issues, but anti-viral medications have been suggested as being potentially effective.
Remdesivir is an anti-viral medication used to treat people admitted to hospital with COVID-19. We don’t know if this works to reduce the symptoms of long COVID and before we conduct a large study to investigate this we need to see if a smaller number of participants are able to tolerate the study processes and the drug. The information gathered from this study will be used to inform the design of a larger future trial, which will determine whether Remdesivir can be used as a treatment for long COVID.
Faculty of Health